Cancer de l'enfant: particularités épidémiologiques ,
Epidémiologie des cancers de l'enfant Late effects of cancer treatment: methods and techniques for detection, Semin Oncol, vol.31, issue.1, pp.87-90, 1974. ,
Second Malignancy in Acute Lymphocytic Leukemia, American Journal of Diseases of Children, vol.135, issue.4, pp.313-319, 1960. ,
DOI : 10.1001/archpedi.1981.02130280003002
Second Malignant Neoplasms in Childhood Cancer Survivors, Journal of Pediatric Oncology Nursing, vol.6, issue.1, pp.7-11, 1989. ,
DOI : 10.1177/104345428900600103
Second malignant neoplasms after cancer in childhood and adolescence: a population-based casecontrol study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries, Int J Cancer. Nov, vol.1588, issue.4, pp.672-680, 2000. ,
Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey, Journal of Korean Medical Science, vol.31, issue.8, pp.1254-61, 2016. ,
DOI : 10.3346/jkms.2016.31.8.1254
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues, Cancer, vol.1400, issue.1, pp.23-35, 2009. ,
DOI : 10.1002/cncr.23988
Hématologie clinique et biologique ,
Rôle de la niche mésenchymateuse dans la régulation du phénotype SP des progéniteurs hématopoïétiques humains, Bull Cancer, 2010. ,
The molecular basis of leukemia. Hematol Educ Program Am Soc Hematol Am Soc Hematol Educ Program, pp.80-97, 2004. ,
Molecular genetics of human leukemias: New insights into therapy, Seminars in Hematology, vol.39, issue.4 ,
DOI : 10.1053/shem.2002.36921
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, issue.6464, 1994. ,
DOI : 10.1038/367645a0
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Feb Nat Med, vol.173673, issue.64647, pp.645-653, 1997. ,
Deregulation of Signaling Pathways in Acute 65 ,
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update, Journal of Clinical Oncology, vol.29, issue.5, pp.551-65, 2011. ,
DOI : 10.1200/JCO.2010.30.7405
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update, Journal of Clinical Oncology, vol.29, issue.5, pp.551-65, 2011. ,
DOI : 10.1200/JCO.2010.30.7405
Implication des gènes du CBF dans la leucémogénèse, pp.30-36, 2000. ,
A systematic description of MLL fusion gene formation, Critical Reviews in Oncology/Hematology, vol.91, issue.3 ,
DOI : 10.1016/j.critrevonc.2014.03.004
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms, Chem Biol Interact, vol.120184, issue.1612, pp.3187-205, 2010. ,
Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group, British Journal of Haematology, vol.1, issue.4, pp.451-459, 1976. ,
DOI : 10.1111/j.1365-2141.1976.tb03563.x
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-51, 2009. ,
DOI : 10.1182/blood-2009-03-209262
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-405, 2016. ,
DOI : 10.1182/blood-2016-03-643544
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891, Blood, vol.91, issue.2, pp.608-623, 1998. ,
Acute Myeloid Leukaemia after Treatment for Acute Lymphoblastic Leukaemia in Girl with Bloom Syndrome, Journal of Genetic Syndromes & Gene Therapy, vol.04, issue.08, 2013. ,
DOI : 10.4172/2157-7412.1000177
Syndromes myélodysplasiques de l'enfant. Rev Fr Lab, 1996. ,
Aplasies médullaires constitutionnelles. EMC -Hématologie, pp.1-12, 2011. ,
Anémie de Blackfan-Diamond : actualités. Rev Oncol Hématologie Pédiatrique, pp.195-204, 2014. ,
La dyskératose congénitale : mise au point. Arch Pédiatrie, pp.299-306, 2013. ,
Acute myeloid leukemia following treatment of hodgkin's disease. A review, Cancer, vol.20, issue.4, pp.676-83, 1982. ,
DOI : 10.1002/1097-0142(19820815)50:4<676::AID-CNCR2820500410>3.0.CO;2-B
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia, New England Journal of Medicine, vol.321, issue.3, 1989. ,
DOI : 10.1056/NEJM198907203210302
Topoisomerase II and the etiology of chromosomal translocations. DNA Repair, pp.9-101093, 2006. ,
Secondary leukemias induced by topoisomerase-targeted drugs Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks Molecular determinants of response to topoisomerase II inhibitors, Biochim Biophys Acta. Med Pediatr Oncol. Bull Cancer, vol.140023, issue.211, pp.1-3233, 1994. ,
Alkylating agents Bull Cancer (Paris), pp.1237-1251, 2011. ,
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group., Journal of Clinical Oncology, vol.15, issue.6, pp.2247-53, 1997. ,
DOI : 10.1200/JCO.1997.15.6.2247
Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Soci??t?? Fran??aise d???Oncologie P??diatrique, Journal of Clinical Oncology, vol.21, issue.6, pp.1074-81, 2003. ,
DOI : 10.1200/JCO.2003.04.100
Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia, Journal of Clinical Oncology, vol.31, issue.19, pp.312469-76, 2013. ,
DOI : 10.1200/JCO.2012.47.0500
Genetic predisposition in children cancers in 2011, Bull Cancer, issue.5, pp.459-475, 2011. ,
Molecular cytogenetics of childhood acute myelogenous leukaemias, European Journal of Haematology, vol.85, issue.Suppl 1, pp.1-13, 1997. ,
DOI : 10.1111/j.1600-0609.1997.tb00953.x
Anomalies chromosomiques dans les leuc??mies aigu??s my??lo??des, Pathologie Biologie, vol.51, issue.6, pp.314-342, 2003. ,
DOI : 10.1016/S0369-8114(03)00114-7
Secondary Adult Acute Myeloid Leukemia: a Review of Our Evolving Understanding of a Complex Disease Process, Current Treatment Options in Oncology, vol.117, issue.4, pp.11864-11879, 2015. ,
DOI : 10.1007/s11864-015-0355-3
Toxicités cardiaques des anthracyclines en oncologie pédiatrique : de la clinique à la pharmacogénétique. Rev Oncol Hématologie Pédiatrique, pp.70-77, 2015. ,
Growth in children after bone marrow transplantation for acute leukemia, Blood. Jul, vol.1586, issue.2, pp.819-843, 1995. ,
Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study. Haematologica, pp.747-56, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01358588
Renal late effects in patients treated for cancer in childhood] Bull Cancer (Paris) FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies, Leuk Res, vol.10226, issue.7 88, pp.627-662, 2002. ,
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience, Ann Hematol, vol.82, issue.4, pp.231-236, 2003. ,
Primary Resistant or Relapsed Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.26, issue.32, pp.5192-5199, 2008. ,
DOI : 10.1200/JCO.2007.15.9764
Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia, Journal of Pediatric Hematology/Oncology, vol.31, issue.11, pp.803-814, 2009. ,
DOI : 10.1097/MPH.0b013e3181ba43dc
Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer ? An update, Leuk Lymphoma, vol.100, issue.2, pp.427-461, 2002. ,
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.93, issue.3, pp.658-67, 2015. ,
DOI : 10.1016/j.ijrobp.2015.07.2270
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry, American Journal of Hematology, vol.102, issue.3, pp.208-222, 2015. ,
DOI : 10.1002/ajh.23908
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia, Oncol Lett. 2016, vol.12, issue.1, pp.262-270 ,
Treatment of therapy-related leukemia and myelodysplastic syndrome, Hematol Oncol Clin North Am. Feb, vol.7, issue.1, pp.81-107, 1993. ,
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation, Haematologica, vol.94, issue.4, pp.542-551, 2009. ,
DOI : 10.3324/haematol.2008.000927
Therapyrelated acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy*: Therapy-related acute promyelocytic leukemia, Eur J Haematol, 2012. ,
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, vol.18, issue.1, pp.120-125, 2004. ,
DOI : 10.1038/sj.leu.2403187
Therapy-related leukemia associated with alkylating agents, Medical and Pediatric Oncology, vol.18, issue.5, pp.536-576, 2001. ,
DOI : 10.1002/mpo.1126
Role of Radiation Dose in the Risk of Secondary Leukemia After a Solid Tumor in Childhood Treated Between 1980 and 1999, International Journal of Radiation Oncology*Biology*Physics, vol.78, issue.5, pp.1474-82, 1980. ,
DOI : 10.1016/j.ijrobp.2009.09.032
Second malignancies after treatment for Ewing???s sarcoma: a report of the CESS-studies, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.2, pp.379-84, 1998. ,
DOI : 10.1016/S0360-3016(98)00228-4
Therapyrelated myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group, Blood, 2007. ,
Acute nonlymphocytic leukemia developing during the course of Ewing's sarcoma, Medical and Pediatric Oncology, vol.221, issue.3, pp.46-51, 1984. ,
DOI : 10.1002/mpo.2950120310
Second cancers in patients with the Ewing sarcoma family of tumours, European Journal of Cancer, vol.44, issue.7, 1990. ,
DOI : 10.1016/j.ejca.2008.02.027
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study, Ann Oncol Off J Eur Soc Med Oncol ESMO, 2001. ,
Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor Study, Journal of Clinical Oncology, vol.27, issue.14, pp.2374-81, 2009. ,
DOI : 10.1200/JCO.2008.21.1839
suivi prolongé après traitement d'une leucémie aiguë de l'enfance : structuration, résultats et perspectives. Rev Oncol Hématologie Pédiatrique, pp.90-98, 2014. ,
Approches méthodologiques en pharmacogénétique : le modèle des leucémies aiguës lymphoblastiques de l'enfant. Rev Oncol Hématologie Pédiatrique, pp.215-235, 2015. ,
Genetic predisposition and treatment-related leukemia, Medical and Pediatric Oncology, vol.28, issue.5, pp.541-549, 2001. ,
DOI : 10.1002/mpo.1127
Therapy-Related Myelodysplasia and Acute Myeloid Leukemia, Seminars in Oncology, vol.40, issue.6, pp.666-75, 2013. ,
DOI : 10.1053/j.seminoncol.2013.09.013
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide., Journal of Clinical Oncology, vol.11, issue.2, pp.209-226, 1993. ,
DOI : 10.1200/JCO.1993.11.2.209
Second malignancies after childhood Hodgkin's disease: The memorial sloan-kettering cancer center experience, Cancer, vol.310, issue.7, pp.1364-70, 1988. ,
DOI : 10.1002/1097-0142(19881001)62:7<1364::AID-CNCR2820620721>3.0.CO;2-T
Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations, Medical and Pediatric Oncology, vol.84, issue.3, pp.165-174, 1998. ,
DOI : 10.1002/(SICI)1096-911X(199803)30:3<165::AID-MPO7>3.0.CO;2-F
21)(q22;q22), *PML/RARA inv(16)(p13.1q22)p22;q23),*MLLT3/KMT2A t(6;9)(p23;q34),*DEK/NUP214 inv(3)(q21q26,2),*GATA2,MECOM t ,